Hyponatremia associated with Ipilimumab-induced hypophysitis.

Abstract

A 75-year-old woman with a history of stage IV metastatic melanoma underwent treatment with the CTLA-4 blocking agent Ipilimumab. She presented 2 months after initiating treatment with a severe headache. Laboratories were consistent with severe hyponatremia. MRI of the brain revealed enlargement of the pituitary gland, enhancement of the infundibulum, and… (More)
DOI: 10.1007/s12032-010-9794-7

2 Figures and Tables

Topics

  • Presentations referencing similar topics